Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD

European Respiratory Journal

Volumn 40, Issue 5, 2012, Pages 1098-1105

  Van Den Berge, Maarten ^a,b   Vonk, Judith M ^a,b   Gosman, Margot ^c   Lapperre, Thérèse S ^d   Snoeck Stroband, Jiska B ^e   Sterk, Peter J ^f   Kunz, Lisette I Z ^d   Hiemstra, Pieter S ^d   Timens, Wim ^a,b   Ten Hacken, Nick H T ^a,b   Kerstjens, Huib A M ^a,b   Postma, Dirkje S ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Groningen Research Institute for Asthma and COPD   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d University Medical Center   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Bronchial biopsies; Bronchial hyperresponsiveness; Chronic obstructive pulmonary disease; Methacholine; Neutrophils; Sputum

Indexed keywords

FLUTICASONE; METHACHOLINE; SALMETEROL;

ADULT; AGED; ARTICLE; BODY PLETHYSMOGRAPHY; BRONCHUS BIOPSY; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS; SYNDROME DELINEATION; TOTAL LUNG CAPACITY; TREATMENT DURATION;

BRONCHIAL HYPERREACTIVITY; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 84868565174     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00169711     Document Type: Article

References (33)

1. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002; 51: 1-16.
2. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276.
3. Tashkin DP, Altose MD, Bleecker ER, et al. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis 1992; 145: 301-310.
4. van den Berge M, Meijer RJ, Kerstjens HAM, et al. PC20 adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC20 methacholine. Am J Respir Crit Care Med 2001; 163: 1546-1550.
5. Wardlaw AJ, Dunnette S, Gleich GJ, et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137: 62-69.
6. Ramsdale EH, Hargreave FE. Differences in airway responsiveness in asthma and chronic airflow obstruction. Med Clin North Am 1990; 74: 741-751.
7. Postma DS, Kerstjens HAM. Characteristics of airway hyperre-sponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: S187-S192.
8. Xu X, Rijcken B, Schouten JP, et al. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997; 350: 1431-1434.
9. Postma DS, de Vries K, Koeter GH, et al. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactiv-ity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis 1986; 134: 276-280.
10. Tashkin DP, Altose MD, Connett JE, et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 1996; 153: 1802-1811.
11. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381-390.
12. Lapperre TS, Snoeck-Stroband JB, Gosman MM, et al. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2009; 151: 517-527.
13. Cockcroft DW. Direct challenge tests: Airway hyperresponsive-ness in asthma: its measurement and clinical significance. Chest 2010; 138: 18S-24S.
14. Quanjer PH, Tammeling GJ, Cotes JE, et al. Symbols, abbreviations and units. Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J 1993; 6: Suppl. 16, 5-40.
15. van den Berge M, Kerstjens HAM, de Reus DM, et al. Provocation with adenosine 59-monophosphate, but not methacholine, induces sputum eosinophilia. Clin Exp Allergy 2004; 34: 71-76.
16. Fahy JV, Liu J, Wong H, et al. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147: 1126-1131.
17. Lapperre TS, Snoeck-Stroband JB, Gosman MM, et al. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 499-504.
18. van den Berge M, Kerstjens HAM, Meijer RJ, et al. Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med 2001; 164: 1127-1132.
19. Willemse BW, Ten Hacken NH, Rutgers B, et al. Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD. Eur Respir J 2004; 24: 391-396.
20. Kuwano K, Bosken CH, Pare PD, et al. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148: 1220-1225.
21. Walker PP, Hadcroft J, Costello RW, et al. Lung function changes following methacholine inhalation in COPD. Respir Med 2009; 103: 535-541.
22. Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyperre-sponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999; 159: 1043-1051.
23. Postma DS, Renkema TE, Noordhoek JA, et al. Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic airflow obstruction. Am Rev Respir Dis 1988; 137: 57-61.
24. Baraldo S, Turato G, Badin C, et al. Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax 2004; 59: 308-312.
25. Schmidt D, Rabe KF. Immune mechanisms of smooth muscle hyperreactivity in asthma. J Allergy Clin Immunol 2000; 105: 673-682.
26. Hardaker KM, Downie SR, Kermode JA, et al. Predictors of airway hyperresponsiveness differ between old and young patients with asthma. Chest 2011; 139: 1395-1401.
27. Wagers S, Lundblad LK, Ekman M, et al. The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? J Appl Physiol 2004; 96: 2019-2027.
28. Irvin CG, Bates JH. Physiologic dysfunction of the asthmatic lung: what's going on down there, anyway? Proc Am Thorac Soc 2009; 6: 306-311.
29. Kanner RE, Connett JE, Altose MD, et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med 1994; 150: 956-961.
30. Martinez FJ, Curtis JL, Sciurba F, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007; 176: 243-252.
31. Han MK, Postma D, Mannino DM, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med 2007; 176: 1179-1184.
32. Ali FR, Kay AB, Larche M. Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects. Thorax 2007; 62: 750-757.
33. Gonzalo JA, Qiu Y, Lora JM, et al. Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis. J Immunol 2007; 179: 1740-1750.